Skip to main content
Premium Trial:

Request an Annual Quote

Richard Moran, William Keane, Thomas Tuschl, Geoffrey Burnstock

Premium

Richard Moran has been appointed as senior vice president and CFO of Genta, the company said last week. He succeeds William Keane, who will resign Sept. 23 and will remain a company consultant.

From 2002 until his retirement in 2004, Moran was director for special projects at Johnson and Johnson.


Rockefeller University researcher and RNAi pioneer Thomas Tuschl has won the 2005 Ernst Schering Prize, according to the Ernst Schering Foundation.

He is honored "for his groundbreaking work in the field of RNA interference." Tuschl will receive the award, which comes with €50,000 in prize money, at a ceremony in Berlin on Sept. 21.


Geoffrey Burnstock has joined the scientific advisory board of CytRx, the company said this week.

Burnstock is a professor and director of the Autonomic Neuroscience Institute at the Royal Free & University College Medical School in London. He played a major role in developing CytRx's lead small molecule drug candidate arimoclomol, according to the company.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.